A medical study described in the Times pitting exercise against pills should be incredibly troubling to people who take statins:
...The unmedicated volunteers improved their aerobic fitness significantly after three months of exercise, by more than 10 percent on average. But the volunteers taking the statins gained barely 1 percent on average in their fitness, and some possessed less aerobic capacity at the end of the study than at its start...Whoa - statins are bad for your aerobic fitness. That's not what we want to hear.
...This finding joins a small but accumulating body of other studies indicating that statins can negatively affect exercise response. Lab rodents given statins, for instance, can’t run as far as unmedicated animals, while in humans, marathon runners on statins develop more markers of muscle damage after a race than runners not using the drugs...Whoa - statins promote muscle damage in athletes. I felt muscle damage after one week when I took the Lipitor. Blood tests showed that the drug attacked my liver.
Finally, it's wrong that the Times frames this in an article whose title is a question, Can Statins Cut the Benefits of Exercise?, when the article describes a study that demonstrates it is a fact that statins do cut the benefits of exercise - they promote muscle damage - or in plain terms - statins are bad for you.
Wrong statin. You should take zocor. I have been on it for a quarter of a century. Since my male ancestors all died of heart disease much younger than I am now I must assume the value of statins. Heart disease is generally way down since statins came into common use.
ReplyDeleteGlad you have no problems. I can't speculate - just know my experience and the results I read and I draw conclusions. In the past 25 years smoking is down, diets are improved, stents are common - likely the reasons heart disease mortality is down. Other recent articles show flaws in the statin studies that were published and show that negative studies were suppressed. Remember there are billions of dollars at stake for big pharma, motivation is high to skew the evidence.
ReplyDeleteThe generic versions of the statins available today are hardly the stuff of billions for big pharma, more like pennies a dose. The muscle and liver problems are easily diagnosed for those prone to them.
ReplyDelete